Last update 31 Mar 2025

Botulinum toxin type A(Lanzhou Institute of Biological Products)

Overview

Basic Info

Drug Type
Toxin
Synonyms
Botulinum Toxin Type A, A型肉毒毒素(兰州生物制品研究所), Chintox
+ [2]
Target
Action
inhibitors
Mechanism
SNAP25 inhibitors(Synaptosomal-associated protein 25 inhibitors)
Active Indication
Inactive Indication
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
China (01 Jan 1997),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D00783-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Blepharospasm
China
01 Jan 1997
Skin Diseases
China
01 Jan 1997
Spasm
China
01 Jan 1997
Strabismus
China
01 Jan 1997
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Crow's feetPhase 3
China
28 Mar 2024
Forehead linesPhase 3
China
26 Mar 2024
Masticatory Muscles, Hypertrophy OfPhase 3
China
13 May 2022
Lower limb spasticityPhase 3
China
11 May 2022
Primary Axilary HyperhidrosisPhase 3
China
27 Apr 2022
Multiple SclerosisPhase 3
China
21 Apr 2016
Spinal Cord InjuriesPhase 3
China
21 Apr 2016
Urinary Bladder, OveractivePhase 3
China
21 Apr 2016
Migraine DisordersPhase 3
China
19 Nov 2014
StrokePhase 3
China
02 Sep 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free